Intraindividual variability over time in plasma biomarkers of inflammation and effects of long-term storage

Cancer Causes and Control

Volumn 25, Issue 8, 2014, Pages 969-976

  Hardikar, Sheetal ^a,b,c   Song, Xiaoling ^a   Kratz, Mario ^a,b   Anderson, Garnet L ^a,b   Blount, Patricia L ^a,b   Reid, Brian J ^a,b   Vaughan, Thomas L ^a,b   White, Emily ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Department of Genome Sciences University of Washington ^*  (United States)

Author keywords

C reactive protein; CV; ICC; Interleukin 6; Soluble tumor necrosis factor receptors

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR I; SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR II; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; BARRETT ESOPHAGUS; BLOOD STORAGE; CHRONIC INFLAMMATION; COHORT ANALYSIS; CORRELATION COEFFICIENT; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL ADENOCARCINOMA; FEMALE; HUMAN; IMMUNOASSAY; INTRAINDIVIDUAL VARIABILITY; LONG TERM STORAGE; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; PRESERVATION AND STORAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; ANALYSIS OF VARIANCE; BLOOD; INFLAMMATION; LABORATORY DIAGNOSIS; METABOLISM; MIDDLE AGED; TIME;

AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SPECIMEN HANDLING; TIME FACTORS;

EID: 84904576027     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-014-0396-0     Document Type: Article

References (35)

1. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539-545 (Pubitemid 32173595)
2. Il'yasova D, Colbert LH, Harris TB, Newman AB, Bauer DC, Satterfield S, Kritchevsky SB (2005) Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev 14:2413-2418 (Pubitemid 41437845)
3. Grote VA, Kaaks R, Nieters A, Tjonneland A, Halkjaer J, Overvad K, Skjelbo Nielsen MR, Boutron-Ruault MC, Clavel-Chapelon F, Racine A, Teucher B, Becker S, Pischon T, Boeing H, Trichopoulou A, Cassapa C, Stratigakou V, Palli D, Krogh V, Tumino R, Vineis P, Panico S, Rodriguez L, Duell EJ, Sanchez MJ, Dorronsoro M, Navarro C, Gurrea AB, Siersema PD, Peeters PH, Ye W, Sund M, Lindkvist B, Johansen D, Khaw KT, Wareham N, Allen NE, Travis RC, Fedirko V, Jenab M, Michaud DS, Chuang SC, Romaguera D, Bueno-de-Mesquita HB, Rohrmann S (2012) Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort. Br J Cancer 106(11):1866-1874. doi:10.1038/bjc.2012.172
4. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387-1397 (Pubitemid 38419992)
5. Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, Gao P, Walker M, Thompson A, Sarwar N, Caslake M, Butterworth AS, Amouyel P, Assmann G, Bakker SJ, Barr EL, Barrett-Connor E, Benjamin EJ, Bjorkelund C, Brenner H, Brunner E, Clarke R, Cooper JA, Cremer P, Cushman M, Dagenais GR, D'Agostino RB Sr, Dankner R, Davey-Smith G, Deeg D, Dekker JM, Engstrom G, Folsom AR, Fowkes FG, Gallacher J, Gaziano JM, Giampaoli S, Gillum RF, Hofman A, Howard BV, Ingelsson E, Iso H, Jorgensen T, Kiechl S, Kitamura A, Kiyohara Y, Koenig W, Kromhout D, Kuller LH, Lawlor DA, Meade TW, Nissinen A, Nordestgaard BG, Onat A, Panagiotakos DB, Psaty BM, Rodriguez B, Rosengren A, Salomaa V, Kauhanen J, Salonen JT, Shaffer JA, Shea S, Ford I, Stehouwer CD, Strandberg TE, Tipping RW, Tosetto A, Wassertheil-Smoller S, Wennberg P, Westendorp RG, Whincup PH, Wilhelmsen L, Woodward M, Lowe GD, Wareham NJ, Khaw KT, Sattar N, Packard CJ, Gudnason V, Ridker PM, Pepys MB, Thompson SG, Danesh J (2012) C-reactive protein, fibrinogen, and cardiovascular disease prediction. The New England journal of medicine 367(14):1310-1320. doi:10.1056/NEJMoa1107477
6. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286(3):327-334 (Pubitemid 32656163)
7. Al-Delaimy WK, Jansen EH, Peeters PH, van der Laan JD, van Noord PA, Boshuizen HC, van der Schouw YT, Jenab M, Ferrari P, Bueno-de-Mesquita HB (2006) Reliability of biomarkers of iron status, blood lipids, oxidative stress, vitamin D, C-reactive protein and fructosamine in two Dutch cohorts. Biomarkers 11:370-382
8. Block G, Dietrich M, Norkus E, Jensen C, Benowitz NL, Morrow JD, Hudes M, Packer L (2006) Intraindividual variability of plasma antioxidants, markers of oxidative stress, C-reactive protein, cotinine, and other biomarkers. Epidemiology 17:404-412 (Pubitemid 44305513)
9. Cava F, Gonzalez C, Pascual MJ, Navajo JA, Gonzalez-Buitrago JM (2000) Biological variation of interleukin 6 (IL-6) and soluble interleukin 2 receptor (sIL2R) in serum of healthy individuals. Cytokine 12(9):1423-1425. doi:10.1006/cyto.2000.0714
10. Clendenen TV, Arslan AA, Lokshin AE, Idahl A, Hallmans G, Koenig KL, Marrangoni AM, Nolen BM, Ohlson N, Zeleniuch-Jacquotte A, Lundin E (2010) Temporal reliability of cytokines and growth factors in EDTA plasma. BMC Res Notes 3:302. doi:10.1186/1756-0500-3-302
11. DeGoma EM, French B, Dunbar RL, Allison MA, Mohler ER 3rd, Budoff MJ (2012) Intraindividual variability of C-reactive protein: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 224(1):274-279. doi:10.1016/j. atherosclerosis.2012.07.017
12. Epstein MM, Breen EC, Magpantay L, Detels R, Lepone L, Penugonda S, Bream JH, Jacobson LP, Martinez-Maza O, Birmann BM (2013) Temporal stability of serum concentrations of cytokines and soluble receptors measured across two years in low-risk HIV-seronegative men. Cancer Epidemiol Biomarkers Prev 22(11):2009-2015. doi:10.1158/1055-9965.EPI-13-0379
13. Gonzalez C, Cava F, Ayllon A, Guevara P, Navajo JA, Gonzalez-Buitrago JM (2001) Biological variation of interleukin-1beta, interleukin-8 and tumor necrosis factor-alpha in serum of healthy individuals. Clinical Chem Lab Med 39(9):836-841. doi:10.1515/CCLM.2001.139 (Pubitemid 32899135)
14. Gu Y, Zeleniuch-Jacquotte A, Linkov F, Koenig KL, Liu M, Velikokhatnaya L, Shore RE, Marrangoni A, Toniolo P, Lokshin AE, Arslan AA (2009) Reproducibility of serum cytokines and growth factors. Cytokine 45:44-49
15. Ho GY, Xue XN, Burk RD, Kaplan RC, Cornell E, Cushman M (2005) Variability of serum levels of tumor necrosis factor-alpha, interleukin 6, and soluble interleukin 6 receptor over 2 years in young women. Cytokine 30:1-6 (Pubitemid 40387349)
16. Hofmann JN, Yu K, Bagni RK, Lan Q, Rothman N, Purdue MP (2011) Intra-individual variability over time in serum cytokine levels among participants in the prostate, lung, colorectal, and ovarian cancer screening trial. Cytokine 56(2):145-148. doi:10.1016/j.cyto.2011.06.012
17. Kayaba K, Ishikawa S, Gotoh T, Nago N, Kajii E, Nakamura Y, Kario K (2000) Five-year intra-individual variability in C-reactive protein levels in a Japanese population-based study: the Jichi Medical School Cohort Study at Yamato, 1993-1998. Jpn Circ J 64(4):303-308 (Pubitemid 30198387)
18. Lee SA, Kallianpur A, Xiang YB, Wen W, Cai Q, Liu D, Fazio S, Linton MF, Zheng W, Shu XO (2007) Intra-individual variation of plasma adipokine levels and utility of single measurement of these biomarkers in population-based studies. Cancer Epidemiol Biomarkers Prev 16:2464-2470 (Pubitemid 351196382)
19. Nasermoaddeli A, Sekine M, Kagamimori S (2006) Intra-individual variability of high-sensitivity C-reactive protein: agerelated variations over time in Japanese subjects. Circ J 70:559-563
20. Navarro SL, Brasky TM, Schwarz Y, Song X, Wang CY, Kristal AR, Kratz M, White E, Lampe JW (2012) Reliability of serum biomarkers of inflammation from repeated measures in healthy individuals. Cancer Epidemiol Biomarkers Prev 21(7):1167-1170. doi:10.1158/1055-9965.EPI-12-0110
21. Ockene IS, Matthews CE, Rifai N, Ridker PM, Reed G, Stanek E (2001) Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem 47:444-450 (Pubitemid 32222458)
22. Rao KM, Pieper CS, Currie MS, Cohen HJ (1994) Variability of plasma IL-6 and crosslinked fibrin dimers over time in community dwelling elderly subjects. Am J Clin Pathol 102:802-805
23. Hardikar S, Onstad L, Blount PL, Odze RD, Reid BJ, Vaughan TL (2013) The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus. PLoS ONE 8(1):e52192. doi:10.1371/journal.pone.0052192
24. Vaughan TL, Kristal AR, Blount PL, Levine DS, Galipeau PC, Prevo LJ, Sanchez CA, Rabinovitch PS, Reid BJ (2002) Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 11(8):745-752 (Pubitemid 34851909)
25. Ertan A, Younes M (2000) Barrett's esophagus. Dig Dis Sci 45:1670-1673
26. Oh DS, Demeester SR (2010) Pathophysiology and treatment of Barrett's esophagus. World J Gastroenterol 16:3762-3772
27. Shrout PE, Fleiss JL (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86(2):420-428
28. Rosner B (2000) Fundamentals of biostatistics, vol 5th. Vol book, whole. Duxbury, Pacific Grove
29. Thavasu PW, Longhurst S, Joel SP, Slevin ML, Balkwill FR (1992) Measuring cytokine levels in blood. Importance of anticoagulants, processing, and storage conditions. J Immunol Methods 153(1-2):115-124
30. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW (1999) C-Reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19:972-978 (Pubitemid 29177345)
31. White E (2011) Measurement error in biomarkers: sources, assessment, and impact on studies. IARC Sci Publ 163:143-161
32. White E, Armstrong BK, Saracci R (2008) Principles of exposure measurement in epidemiology, 2nd edn, vol book, whole. Oxford University Press, USA
33. de Jager W, Bourcier K, Rijkers GT, Prakken BJ, Seyfert-Margolis V (2009) Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol 10:52
34. Tworoger SS, Hankinson SE (2006) Use of biomarkers in epidemiologic studies: minimizing the influence of measurement error in the study design and analysis. Cancer Causes Control 17(7):889-899. doi:10.1007/s10552-006-0035-5 (Pubitemid 44078280)
35. House RV (2001) Cytokine measurement techniques for assessing hypersensitivity. Toxicology 158(1-2):51-58